CompaniesStentys

Stentys

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

4

As Collaborator

2

Total Enrollment

3,626

By Phase

NA: 1PHASE3: 2PHASE4: 1

By Status

COMPLETED: 3UNKNOWN: 2TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
NCT01538446
NCT01732341
NCT02385279
NCT02800837
NCT03115281
Hover over trial bars to see details

Recent Trials

NCT03115281Lead Sponsor
Registry to Assess the STENTYS Xposition S for Revascularization of Coronary Arteries In Routine cliNical Practice
N/AUnknown
750 participants
Started: Mar 20, 2017 · Completed: Jul 31, 2020
NCT02800837Lead Sponsor
Clinical Study to Evaluate the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease
N/AUnknown
200 participants
Started: May 31, 2016 · Completed: Jun 30, 2019
NCT02385279Collaborator
Study Comparing the MiStent SES Versus the XIENCE EES Stent
NACompleted
1,398 participants
Started: Mar 20, 2015 · Completed: Feb 4, 2021
NCT01732341Lead Sponsor
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
PHASE3Terminated
318 participants
Started: May 31, 2013 · Completed: Mar 31, 2017
NCT01538446Collaborator
Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel
PHASE4Completed
880 participants
Started: Mar 31, 2012 · Completed: May 31, 2016
View all 6 trials →